Science Explorer Back to mapMap
Discussion
Researcher · Arqule (United States) · United States

Sudharshan Eathiraj

Sudharshan Eathiraj publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, on topics such as Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations and PI3K/AKT/mTOR signaling in cancer.

ORCID 0000-0002-7260-8846 OpenAlex
World rank
#415,988
of 7,710,434 ranked researchers
Rank in United States
#147,077
of 1,627,098
Works
79
Citations
2.2k
Citations per work
27.9
h-index
20
i10-index 22Top 33% in Molecular Biology
Sudharshan Eathiraj

What does Sudharshan Eathiraj research?

Sudharshan Eathiraj's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (36%).

Health Sciences: 35 works · 44.0% of their workMedicine: 35 works · 44.0% of their workPulmonary and Respiratory Medicine: 12 works · 15.6% of their workGenetics: 10 works · 12.1% of their workOncology: 9 works · 11.3% of their workHematology: 4 works · 5.0% of their workLife Sciences: 28 works · 35.5% of their workBiochemistry, Genetics and Molecular Biology: 28 works · 35.5% of their workMolecular Biology: 23 works · 29.1% of their workCell Biology: 5 works · 6.4% of their workEverything else: 16 works · 20.5% of their workTHEIR WORKSudharshanEathiraj79works
Life Sciences36%Health Sciences44%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3544.0%
    1. Biochemistry, Genetics and Molecular Biology2835.5%
  3. Everything else1620.5%
  1. 1Molecular Biology29% of their works
  2. 2Pulmonary and Respiratory Medicine16% of their works
  3. 3Genetics12% of their works
  4. 4Oncology11% of their works
  5. 5Cell Biology6% of their works
  6. 6Hematology5% of their works

Research topics

Which keywords describe Sudharshan Eathiraj's research?

The keywords of their largest research topics: Cancer, Signaling, Chronic Lymphocytic Leukemia, Genomic Aberrations, EGFR Mutations, Targeted Therapy, Metastatic Breast Cancer and mTOR.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer152 topics
  2. Signaling152 topics
  3. Chronic Lymphocytic Leukemia141 topic
  4. Genomic Aberrations141 topic
  5. EGFR Mutations131 topic
  6. Targeted Therapy131 topic
  7. Metastatic Breast Cancer102 topics
  8. PI3K/AKT pathway91 topic
  9. mTOR91 topic
  10. Endocytosis71 topic
  11. Membrane Fusion71 topic
  12. Cetuximab61 topic
  13. FGF2161 topic
  14. Fibroblast Growth Factor61 topic
  15. KRAS Mutations61 topic
  16. Breast Cancer51 topic
  17. CDK4/6 Inhibitors51 topic
  18. Chemotherapy-Induced Peripheral Neuropathy51 topic
  19. Taxanes51 topic

Where does Sudharshan Eathiraj work?

Sudharshan Eathiraj's main affiliation in the publication record is Arqule (United States), United States.

How many publications and citations does Sudharshan Eathiraj have?

OpenAlex counts 79 works and 2,205 citations for Sudharshan Eathiraj, an h-index of 20, ranking #415,988 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sudharshan Eathiraj. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.